Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial

To examine the changes in vision-specific and overall health-related quality of life (QOL) at 6 months in participants with idiopathic intracranial hypertension (IIH) and mild visual loss enrolled in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) and to determine the signs and symptoms of IIH that mediate the effect of acetazolamide on QOL.We assessed QOL using the National Eye Institute Visual Function Questionnaire-25...